Article

Research progress on the role and mechanism of blood-brain barrier dysfunction in Alzheimer's disease

2024-07-30

Abstract excerpt

The prevalence of Alzheimer’s disease (AD) is on the rise due to the global aging population. AD is the most common cause of dementia, accounting for 60-80% of all cases, which makes it a significant health concern. In recent years, the failure to develop targeted pathological drugs has led researchers to shift their focus. The blood-brain barrier (BBB) is a specialized structure that separates the circulating blo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 03e50927-6451-5cfc-ad3c-b5bdbcc2a282
DOI: 10.22541/au.172232859.94732814/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Research progress on the role and mechanism of blood-brain barrier dysfunction in Alzheimer's diseaseDOI 10.22541/au.172232859.94732814/v1Read

Alzheimer's disease: A matter of blood-brain barrier dysfunction?Semantic proximity Read

Detrimental Effects of ApoE ε4 on Blood–Brain Barrier Integrity and Their Potential Implications on the Pathogenesis of Alzheimer’s DiseaseSemantic proximity Read

Blood-Brain Barrier Dysfunction and Aβ42/40 Ratio Dose-Dependent Modulation with the ApoE Genotype within the ATN Framework.Semantic proximity Read

Spotlight on the Pathophysiological Trajectories Linked to Alzheimer’s Disease (AD): Blood-Brain Barrier (BBB); Neuroinflammation; APOE4 Allele and AD- Insulin Resistance (IR) Pathogenic LinkSemantic proximity Read

Interplay Between Vascular Dysfunction and Neurodegenerative Pathology: New Insights into Molecular Mechanisms and ManagementSemantic proximity Read

APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's DiseaseSemantic proximity Read

APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and TherapeuticsSemantic proximity Read

ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies.Semantic proximity Read

Navigation Between Alzheimer’s Disease (AD) and Its Various Pathophysiological Trajectories: The Pathogenic Link to Neuroimmunology—Genetics and NeuroinflammationSemantic proximity Read

Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic StrategiesSemantic proximity Read

The “Frail” Brain Blood Barrier in Neurodegenerative Diseases: Role of Early Disruption of Endothelial Cell to Cell ConnectionsSemantic proximity Read

<i>APOE-</i> ε4-induced Fibronectin at the blood-brain barrier is a conserved pathological mediator of disrupted astrocyte-endothelia interaction in Alzheimer’s diseaseSemantic proximity Read